Prabhudas Lilladher's research report on Laxmi Organic Industries
We cut our FY24/25E EPS estimates by 18%/13% and reduce the TP to Rs300 (SOTP based) vs Rs335 earlier (implied consol FY25E EV/EBITDA of 16x and PE of 24x), given (1) slower than expected revenue growth in Specialty Intermediates (SI) segment ex-new long term contract, on persisting demand weakness in some key applications (2) sharp price correction (ETAC price down >30%YoY) and normalization of spreads in Acetyls (AI) and (3) slow execution of Fluorochemicals plant setup and no. of product launches curtailed further to 6-8 (vs 8-10 earlier); supply contracts still awaited.
Outlook
We believe, SI and AI will remain LXCHEM’s core businesses in the medium term (SI revenue visibility remains high given long term contracts), while FI will be a long term earnings driver. EBITDA contribution from higher value segments (SI+FI) will increase to ~70% by FY25E from ~55% in FY22 as SI EBITDA grows at ~16% CAGR and FI earnings commence in Q4FY23. We maintain ‘HOLD’ rating given correction in the stock price.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.